Michael F. Sarosdy

Urology San Antonio — United States

Medicine · Health Sciences

33h-index10.6kcitations107works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bladder and Urothelial Cancer Treatments(50), Urinary and Genital Oncology Studies(32), Prostate Cancer Treatment and Research(27), Prostate Cancer Diagnosis and Treatment(22), Hormonal and reproductive studies(14)

Publications107 total

Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer
The Journal of Urology·2015· 63 cited
566: High Disease-Free Survival 5-10 Years after Prostate Brachytherapy Associated with Negative Prostatic Biopsies among Failures
The Journal of Urology·2007Open Access
Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy
Cancer·2006· 184 citedOpen Access
Use of a Multitarget Fluorescence In Situ Hybridization Assay to Diagnose Bladder Cancer in Patients With Hematuria
The Journal of Urology·2006· 112 cited
1138: Testosterone Replacement after Brachytherapy for Prostate Cancer
The Journal of Urology·2006
890: Multiple Fluorescence in Situ Hybridization (FISH) Probes Increase Sensitivity for Detection of Bladder Cancer
The Journal of Urology·2006· 1 cited
Androgen replacement therapy for hypogonadism after brachytherapy for prostate cancer
Brachytherapy·2006
Hypogonadism is more common than expected in men about to undergo prostate brachytherapy, independent of age and degree of erectile dysfunction
Brachytherapy·2006
A phase II clinical trial of oral bropirimine in combination with intravesical bacillus Calmette-Guérin for carcinoma in situ of the bladder: A Southwest Oncology Group Study
Urologic Oncology Seminars and Original Investigations·2005· 9 citedOpen Access
Author reply
Cancer·2005Open Access
Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy
Cancer·2004· 60 citedOpen Access
Surgical Factors Influence Bladder Cancer Outcomes: A Cooperative Group Report
Journal of Clinical Oncology·2004· 597 citedOpen Access
1070: Pulmonary Seed Migration after Permanent Transperineal Prostate Brachytherapy is Relatively Common
The Journal of Urology·2004
252: Evaluation of a Multi-Target Fluorescent in Situ Hybridization (FISH) Assay in the Initial Diagnosis of Bladder Cancer in Patients with Hematuria
The Journal of Urology·2004· 7 cited
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
New England Journal of Medicine·2003· 2.6k citedOpen Access
Clinical Evaluation of a Multi-target Fluorescent in Situ Hybridization Assay for Detection of Bladder Cancer
The Journal of Urology·2002· 2 cited
Clinical Evaluation of a Multi-target Fluorescent in Situ Hybridization Assay for Detection of Bladder Cancer
The Journal of Urology·2002· 258 cited
Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer.
PubMed·2002· 273 cited
Advanced bladder cancer...Where are we now and where are we going?
World Journal of Urology·2002
Sector analysis of prostate implants
Medical Physics·2001· 21 cited
page 1 of 6Next →

Frequent Co-authors

Donald L. Lamm(15), Mark S. Soloway(12), Paul F. Schellhammer(10), Nicholas J. Vogelzang(6), Brent A. Blumenstein(6), E. David Crawford(6), Gerald W. Chodak(5), Edward M. Messing(5), Geert J.C.M. Kolvenbag(5), H. Barton Grossman(4), Bruce A. Lowe(4), Daniel D. Von Hoff(4), M’Liss A. Hudson(4), Norman L. Block(4), Peter Venner(4), Anthony L. Patterson(4), James E. Montie(3), H. Barton Grossman(3), Ralph Devere White(3), Joseph V. Briggman(3)